Illumina

Qiagen and Illumina in It for the Long Haul with 15-year Collaboration
Qiagen and Illumina in It for the Long Haul with 15-year Collaboration
Medical Devices and Diagnostics Industry
Qiagen
Illumina
diagnostics
oncology
Flag link:
Recent Job Cuts in the Biopharma Industry
Recent Job Cuts in the Biopharma Industry
BioSpace
Tocagen
Sanofi
Amneal
Daiichi Sankyo
Integra Life Sciences
Aclaris
Bayer
Novartis
Illumina
Merck
Roche Molecular Systems
Prometheus Labs
layoffs
Flag link:
Illumina Hits a Speed Bump in the 2nd Quarter
Illumina Hits a Speed Bump in the 2nd Quarter
Motley Fool
Illumina
earnings
Flag link:
Illumina plunges after slashing revenue expectations
Illumina plunges after slashing revenue expectations
CNBC
Illumina
earnings
Flag link:
Element Biosciences Lands $15M to Develop New Genetic Analysis Tools
Element Biosciences Lands $15M to Develop New Genetic Analysis Tools
Xconomy
DNA sequencing
gene sequencing
Illumina
Element Biosciences
Flag link:
Complete Genomics Files Lawsuit Against Illumina
Complete Genomics Files Lawsuit Against Illumina
Medical Devices and Diagnostics Industry
Illumina
Complete Genomics
patents
diagnostics
gene sequencing
Flag link:
Where Will Illumina Be in 10 Years?
Where Will Illumina Be in 10 Years?
Motley Fool
Illumina
gene sequencing
Flag link:
Illumina Reports Its Q1 Results on Thursday: 3 Things You Can Expect
Illumina Reports Its Q1 Results on Thursday: 3 Things You Can Expect
Motley Fool
Illumina
earnings
Pacific Biosciences
Flag link:
Pump the Brakes on the Illumina and Pacific Biosciences Deal
Pump the Brakes on the Illumina and Pacific Biosciences Deal
Motley Fool
Illumina
Pacific Biosciences
DNA sequencing
M&A
Flag link:
3 Things You Can Expect From Illumina's Q4 Earnings Update
3 Things You Can Expect From Illumina's Q4 Earnings Update
Motley Fool
Illumina
gene sequencing
earnings
Flag link:
[video+transcript]Why Alkermes' Depression Drug Stumbled, and How Illumina Plans to Profit From M&A
[video+transcript]Why Alkermes' Depression Drug Stumbled, and How Illumina Plans to Profit From M&A
Motley Fool
Alkermes
depression
ALSK-5461
opioids
Illumina
Pacific Biosciences
Flag link:
Where Will Illumina, Inc. Be in 10 Years?
Where Will Illumina, Inc. Be in 10 Years?
Motley Fool
Illumina
genomic sequencing
Flag link:
Illumina taking out Pacific Biosciences for $1.2B
Illumina taking out Pacific Biosciences for $1.2B
BioCentury
Illumina
Pacific Biosciences
M&A
genomics
Flag link:
Here's Why Illumina Stock Has Gained 28.3% in 2018 (So Far)
Here's Why Illumina Stock Has Gained 28.3% in 2018 (So Far)
Motley Fool
Illumina
DNA sequencing
NovaSeq
Flag link:
Here's Why Illumina, Inc. Stock Gained 13.1% in May
Here's Why Illumina, Inc. Stock Gained 13.1% in May
Motley Fool
Illumina
gene sequencing
Edico Genome
M&A
Flag link:
A Need for Speed: Illumina Acquires San Diego’s Edico Genome
A Need for Speed: Illumina Acquires San Diego’s Edico Genome
Xconomy
Illumina
Edico Genome
M&A
Flag link:
Bristol Partners With Illumina On Diagnostic Test To Use With Opdivo
Bristol Partners With Illumina On Diagnostic Test To Use With Opdivo
Forbes
Bristol-Myers Squibb
Illumina
DNA sequencing
Opdivo
diagnostics
Flag link:
How biotech firm Illumina smooths out buying for online customers
How biotech firm Illumina smooths out buying for online customers
Digital Commerce 360
Illumina
genomics
e-commerce
Flag link:
5 Reasons Illumina Enjoyed a Big J.P. Morgan Conference Bounce
5 Reasons Illumina Enjoyed a Big J.P. Morgan Conference Bounce
Motley Fool
Illumina
JPMHC 2018
NovaSeq
iSeq
Thermofisher
gene sequencing
Flag link:
Illumina Unveils $20,000 Desktop Sequencer Aimed At Sequencing Germs
Illumina Unveils $20,000 Desktop Sequencer Aimed At Sequencing Germs
Forbes
Illumina
DNA sequencing
iSeq
JPMHC 2018
Flag link:

Pages